← FDA Drug Approvals (Drugs@FDA)

RECLAST

NDA · New Drug Application · Sponsor: SANDOZ · Approved 2007-08-17

Drug application

FDA Application #

NDA022080

Application type

New Drug Application

Brand name

RECLAST

Generic name

Zoledronic Acid

Active ingredients

ZOLEDRONIC ACID

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SANDOZ

First approval

2007-08-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown